Our mission
We aim to provide our customers with scientifically sound and efficient anti-aging products and services.
Our approach
At CELFULL, we employ a unique approach that combines AI network pharmacology with aging biology. Our goal is to discover the most promising natural compositions to combat aging and age-related diseases.
Our vision is to sustain a long-term, healthy enterprise.
We are dedicated to understanding the nine major mechanisms of aging and offer personalized aging-intervention solutions. Our AI Multi-Target Anti-Aging Research Institute encompasses several platforms, including the Aging Mechanism Research Platform, AI Network Pharmacology Platform, TurnA Drug Delivery Platform, and Product Evaluation and Clinical Research Platform.
DR. JULIANE HITZEL
Holds a Ph.D. in Biochemistry from the Goethe University Frankfurt
Holding a Ph.D. in Biochemistry from Goethe University Frankfurt, I am deeply committed to advancing life sciences. At CELFULL, we are passionate about bringing cutting-edge technologies to consumers worldwide, enhancing their health and longevity. As a researcher, I am fascinated by the depth and breadth of life science. I delve into the mysteries of human body mechanisms daily, exploring ways to improve quality of life and extend human lifespan through technology. Our team specializes in cell repair, gene editing, and applying AI in biotechnology, continually inspiring me with our groundbreaking research.
Our Story
2001
The Genesis of CELFULL: From Laboratory Innovations to Biotech Excellence
CELFULL® traces its roots back to the esteemed laboratory of Professor Wu Rui at Cornell University, a hub of significant scientific achievements. It is in this very lab where one of our founders began his post-doctoral journey, immersed in the study of enzyme catalysis technology. This laboratory is renowned not only for its groundbreaking research but also for being the alma mater of distinguished scientists. Through years of dedicated research and innovation, our founder secured over ten international patents, laying the groundwork for CELFULL's pioneering contributions to the field of biotechnology.
2008
The Newborn Biotech Start-up Focused on Anti-aging
The CELFULL brand was officially established and the official website www.celfull.com was created, hoping to solve a series of health problems related to age and aging, rejuvenate the body, and extend human lifespan and healthspan.
2016
CELFULL made contributions in uncovering the science behind NAD+ research
CELFULL provided first-gen NMN as scientific materials for Prof. David Sinclair, who is a Professor in the Department of Genetics at Harvard Medical School, best known for his work on understanding why we age and how to slow its effects. The Sinclair lab was the first to identify a role for NAD biosynthesis in the regulation of lifespan.
2017
CELFULL welcome the join of Prof. George Birkmayer
CELFULL hires George Birkmayer as first chief scientist, who is renowned as the father of NADH application.
2020
CELFULL persists in high quality and safety standards
CELFULL achieved toxicology test reports and safety evaluation reports for its core anti-aging materials NMN and NADH provided by authority organization, which is leading in the industry.
2022
CELFULL Luanched Hebe Lab
Hebe Lab is committed to building a global anti-aging integration technology platform. Leveraging existing aging intervention technology, the lab conducts real-world research to develop systematic anti-aging solutions.
2023
CELFULL Prompted AI multi-target Anti-aging Research
CELFULL hold the first symposium of AI multi-target Anti-aging Research and Application.
2025
CELFULL Unveils Its Self-Developed Celfavor® Microsphere Technology Worldwide at SupplySide Global 2025